AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

Qiagen

Qiagen
Company nameQiagen N.V.
Company typeNaamloze vennootschap
IndustryBiotechnology
Founded1984
HeadquartersVenlo, Netherlands (corporate); Hilden, Germany (operational)
Key peoplePeer Schatz (CEO and chairman of the executive board), Detlev Riesner (Chairman of the supervisory board)
RevenueUS $1.087 billion (2010)
Operating incomeUS $188.5 million (2010)
Net incomeUS $144.3 million (2010)
Total assetsUS $3.914 billion (end 2010)
Total equityUS $2.476 billion (end 2010)
Employees3,590 (end 2010)

     Home | Company | Qiagen





Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries. Qiagen’s shares are listed at the technology-focused U.S. stock exchange Nasdaq (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Peer M. Schatz is the company’s Chief Executive Officer. The main headquarters are located in Hilden, Germany (near Düsseldorf).

Qiagen Video

Automated systems for real-time PCR analysis The challenge of achieving accurate and reliable quantification of DNA and RNA just got easier. QIAGEN provides the optimal solution for real-time PCR - from optimized kits and assays to fully automated PCR setup and outstanding real-time PCR analysis. Discover more at www.qiagen.com/automation.
4.13 min. | 5.0 user rating
The revolutionary QIAxcel system replaces traditional, labor-intensive gel analysis of DNA and RNA. The system allows fast and fully automated, high-resolution analysis of up to 96 samples - streamlining your workflow and reducing time to result. Discover more lab automation solutions from QIAGEN at www.qiagen.com/automation.
3.05 min. | 4.07 user rating
In diesem kurzen Film geht es um die Entwicklung eines Testverfahrens, mit dem sich der gefährliche Vogelgrippe-Erreger nachweisen lässt. Die Entwicklung fand bei der Hamburger Biotech-Firma Artus statt, die schlieÃlich im Jahr 2005 von der Firma Qiagen übernommen wurde. Der Film wurde im Jahr 2007 im Auftrag des Bundesministeriums für Bildung und Forschung (BMBF) erstellt und kann auf der Webseite www.biotechnologie.de kostenlos bestellt werden.
6.62 min. | 4.9 user rating
www.qiagen.com About QIAGEN QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We have developed more than 500 consumable products and automated solutions. We sell these products to academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control. QIAGEN employs more than 2600 people in over 30 locations worldwide.
2.68 min. | 3.5 user rating
RT2 Profiler PCR Arrays deliver highly accurate and reliable expression analysis of a focused panel of genes. Each 96-well plate, 384-well plate, or 100-well disc includes SYBR Green-optimized primer assays for a thoroughly researched panel of relevant, pathway- or disease-focused genes. RT2 Profiler PCR Arrays can also be customized to contain a panel of genes tailored to your specific research interests. QIAGEN´s high-quality primer design and master mix formulation enable the amplification of 96 or 384 different gene-specific products simultaneously under uniform cycling conditions. This combination enables the RT2 Profiler PCR Array to provide the high degree of specificity and amplification efficiency that is required to achieve accurate real-time SYBR Green results. The simplicity of RT2 Profiler PCR Arrays makes them accessible for routine use in every research laboratory. Each array consists of a plate preloaded with validated real-time PCR primers for a panel of pathway-focused genes. The system includes four components: First, the RT² cDNA first strand kit; second, the RT² Profiler PCR Arrays themselves; third, the RT² SYBR Green Master Mix; and fourth, the free online Data Analysis Software that greatly simplifies the analysis of PCR Array data. Learn more about RT2 Profiler PCR Arrays at www.sabiosciences.com
3.17 min. | 5.0 user rating
QIAGEN Tissue Lyser-II ÐÐ»Ñ ÑдобÑÑва погÑÑÐ¶ÐµÐ½Ð¸Ñ ÑаÑиков в пÑобиÑки еÑÑÑ Ð´Ð²Ð° вида диÑпенÑеÑа (изобÑажен в виде Ñиней пипеÑки). Ðа данном видео ÑаÑики ÑÑалÑнÑе - ÑекомендÑÑÑÑÑ Ð´Ð»Ñ ÑвеÑдÑÑ Ð¾Ð±ÑазÑов:коÑÑи, зÑбÑ, кожа. ÐÑÑÑ Ñакже волÑÑÑамово-каÑбиднÑе или ÑÑеклÑннÑе ÑаÑики.
0.13 min. | 1.0 user rating
Benefit from a new dimension of possibilities for purification of nucleic acids and proteins! The powerful and versatile QIAsymphony purifies viral RNA and DNA, cellular RNA, genomic DNA, or proteins from up to 96 samples. Discover more lab automation solutions from QIAGEN at www.qiagen.com/automation.
3.42 min. | 2.33 user rating
The innovative QIAcube uses advanced technology to process QIAGEN spin columns, enabling seamless integration of automated, low-throughput sample prep into your laboratory workflow. Go to www.qiagen.com/qiacube for more information.
2.73 min. | 5.0 user rating
A scientist frustrated with performing time-consuming and repetitive manual work discovers why his colleague in a neighboring lab is so relaxed. Find out more about the QIAcube at www.qiagen.com/qiacube
2.20 min. | 3.66 user rating
www.weforum.org Global Growth Companies Community Partner - Qiagen company
1.28 min. | 0 user rating

Latest News : Qiagen : Tweet this RSS

Want to Qiagen latest news on your twitter account???   sign in with twitter
Qiagen     sign in with twitter   ||  Company     sign in with twitter   ||  Economy     sign in with twitter
Qiagen, Abbott sign contract over HIV, HPV tests - BusinessWeek Tweet this news
BusinessWeek---Qiagen- NV said Tuesday it will receive kits for a molecular test for HIV-1 in a deal with Abbott Laboratories. Financial details of the deal were not ... - Date : Wed, 13 Oct 2010 04:24:40 GMT+00:00
MORGAN STANLEY INITIATED COVERAGE OF QIAGEN WITH EW RATING AS THEY SEE ... - Zacks.com Tweet this news
Zacks.com--Analysts Marshall Urist and Neha Sahni said, "-Qiagen's- long-term strategic position in molecular diagnostics remains attractive, and at a historically low ... - Date : Mon, 25 Oct 2010 18:13:00 GMT+00:00
Qiagen Inks Deal With Abbott - Daily Markets Tweet this news
Daily Markets--Under an agreement with Abbott (NYSE:ABT), -Qiagen- (NASDAQ:QGEN) will receive test kits for a molecular test of HIV in the US and Canada. ... - Date : Mon, 18 Oct 2010 15:27:18 GMT+00:00
QIAGEN - Bears taking control? - TradersHuddle.com Tweet this news
TradersHuddle.com---QIAGEN's- latest price action developed a short term reversal pattern in the form of a tweezer top, which is a candlestick pattern that is usually formed at ... - Date : Tue, 02 Nov 2010 08:42:51 GMT+00:00
QIAGEN - Shares Seeking Direction - TradersHuddle.com Tweet this news
TradersHuddle.com--New York, November 2nd (TradersHuddle.com) - Shares of -QIAGEN- NV (NASDAQ:QGEN) closed the trading day higher by $0.2 or 1.06% from its previous close. ... - Date : Tue, 02 Nov 2010 21:59:11 GMT+00:00
Products allow molecular analysis of FFPE samples - Laboratory Talk Tweet this news
Laboratory Talk---Qiagen- has launched several products that assist in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissue samples. ... - Date : Fri, 05 Nov 2010 03:58:29 GMT+00:00
"Most Promising" China Life Science Companies Named at BioBay Investor Forum - MarketWatch (press release) Tweet this news
MarketWatch (press release)--Dr. Han previously founded Genaco, which was acquired by -Qiagen- for $40 million. Nearly 300 life science investors and executives attended the successful ... - Date : Fri, 05 Nov 2010 13:06:42 GMT+00:00
Will QIAGEN recover? - TradersHuddle.com Tweet this news
TradersHuddle.com--New York, July 28th (TradersHuddle.com) - Shares of -QIAGEN- NV (NASDAQ:QGEN) closed the trading session at $18.67 below calculated support at $19.20 breaking ... - Date : Wed, 28 Jul 2010 05:23:40 GMT+00:00
MdBio Foundation, MedImmune, and Montgomery College Collaborate to Host the ... - PR-CANADA.net (press release) Tweet this news
PR-CANADA.net (press release)--Visits include trips to MedImmune, J. Craig Venter Institute, and -Qiagen-. The week begins with a micropipette challenge, where students mix together ... - Date : Wed, 04 Aug 2010 12:56:35 GMT+00:00
Treating Cervical Cancer, Is there a hope for African women? - Ghana News Agency Tweet this news
Ghana News Agency--A new test, the "careHPV DNA Test (-QIAGEN-)" to detect infection with the types of HPV that causes cervical cancer promises to bring better protection to ... - Date : Wed, 04 Aug 2010 22:18:45 GMT+00:00

TecDAX companies of Germany

Aixtron * BB Biotech * Bechtle * Carl Zeiss Meditec * Centrotherm Photovoltaics * Conergy * Dialog Semiconductor * Drägerwerk * Drillisch * Evotec * Freenet * Jenoptik * Kontron * Manz Automation * MediGene * MorphoSys * Nordex * Pfeiffer Vacuum * Phoenix Solar * Q-Cells * Qiagen * QSC * Roth & Rau * SMA Solar Technology * Singulus Technologies * Smartrac * Software * SolarWorld * United Internet * Wirecard



Privacy | Sitemap | Micra Hosting | USA Yellow Pages